Net profit of Kilitch Drugs (India) declined 4.99% to Rs 8.19 crore in the quarter ended September 2025 as against Rs 8.62 crore during the previous quarter ended September 2024. Sales rose 3.05% to Rs 48.92 crore in the quarter ended September 2025 as against Rs 47.47 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales48.9247.47 3 OPM %10.3012.85 - PBDT10.2610.95 -6 PBT9.4010.35 -9 NP8.198.62 -5 Powered by Capital Market - Live News

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Kilitch Drugs (India) announced that the 33rd Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live News

Net profit of Kilitch Drugs (India) rose 126.12% to Rs 3.03 crore in the quarter ended June 2025 as against Rs 1.34 crore during the previous quarter ended June 2024. Sales rose 28.97% to Rs 43.14 crore in the quarter ended June 2025 as against Rs 33.45 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales43.1433.45 29 OPM %7.564.96 - PBDT4.292.50 72 PBT3.451.65 109 NP3.031.34 126 Powered by Capital Market - Live News

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live News